Key result
Plasma betatrophin concentrations were negatively correlated with insulin secretion capacity, measured by increments of C-peptide concentration (r = 0.37, P = 0.001).
Why the study?
Is there a correlation between plasma betatrophin concentrations and insulin secretion capacity in people with Type 2 diabetes?
Population
70 people with Type 2 diabetes
Design
Cross-sectional
Authors
Loading...
No immediate clinical implications for diabetes care; leaves open betatrophin's biomarker or mechanistic role in beta-cell research.
Cross-Sectional (n=70)
Is there a correlation between plasma betatrophin concentrations and insulin secretion capacity in people with Type 2 diabetes?
Effect estimate: r = 0.37 (negative correlation)
p-value: p=0.001
Plasma betatrophin levels inversely correlate with insulin secretion capacity in patients with Type 2 diabetes.
Tokumoto et al. (2015) conducted a cross-sectional in Type 2 diabetes (n=70). Plasma betatrophin concentrations was evaluated on Correlation with increments of C-peptide concentration in response to glucagon stimulation (r = 0.37 (negative correlation), p=0.001). Plasma betatrophin concentrations were negatively correlated with insulin secretion capacity, measured by increments of C-peptide concentration (r = 0.37, P = 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: